EssilorLuxottica SA Stock
Price
Target price
€242.60
€242.60
-3.150%
-7.9
-3.150%
€290.00
11.07.25 / Tradegate
WKN: 863195 / Symbol: ESLOF / Name: EssilorLuxottica / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
EssilorLuxottica SA Stock
Heavy losses for EssilorLuxottica SA today as the stock fell by -€7.900 (-3.150%).
Currently there is a rather positive sentiment for EssilorLuxottica SA with 3 Buy predictions and 0 Sell predictions.
With a target price of 290 € there is a slightly positive potential of 19.54% for EssilorLuxottica SA compared to the current price of 242.6 €.
So far the community has only identified positive things for EssilorLuxottica SA stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of EssilorLuxottica SA in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of EssilorLuxottica SA vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| EssilorLuxottica SA | -3.150% | 3.720% | -2.492% | 21.239% | 3.542% | 66.735% | 106.908% |
| bioMerieux S.A. | -1.890% | 0.590% | -1.972% | 26.177% | 15.938% | 14.327% | -6.505% |
| Sartorius Stedim Biotech S.A. | -0.880% | 0.246% | 0.992% | 21.106% | 10.857% | -40.630% | -15.125% |
| Baxter International | -3.170% | -6.322% | -10.313% | -24.341% | -11.876% | -61.698% | -67.486% |
Comments
News
EssilorLuxottica Stock: Profit Margins Soar, Smart Eyewear Drives Growth
EssilorLuxottica, the global leader in eyewear and optical products, has demonstrated remarkable financial performance in its latest fiscal year. The Franco-Italian eyewear giant reported a 4.4%
